Arcadia Biosciences Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Public

  • Employees
  • 8

Employees

  • Stock Symbol
  • RKDA

Stock Symbol

  • Investments
  • 11

  • Share Price
  • $0.19
  • (As of Wednesday Closing)

Arcadia Biosciences General Information

Description

Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 5956 Sherry Lane
  • Suite 2000
  • Dallas, TX 75225
  • United States
+1 (530)
Primary Industry
Cultivation
Other Industries
Food Products
Biotechnology
Stock Exchange
NAS
Corporate Office
  • 5956 Sherry Lane
  • Suite 2000
  • Dallas, TX 75225
  • United States
+1 (530)

Arcadia Biosciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Arcadia Biosciences Stock Performance

As of 18-Nov-2026, Arcadia Biosciences’s stock price is $0.19. Its current market cap is $1.14M with 6.07M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.19 $0.19 $0.11 - $3.87 $1.14M 6.07M 2.3M -$3.37

Arcadia Biosciences Financials Summary

As of 30-Sep-2026, Arcadia Biosciences has a trailing 12-month revenue of $5.06M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV (3,503) (3,166) 1,712 (11,092)
Revenue 5,063 4,858 5,045 4,454
EBITDA (10,240) (2,520) (4,978) (5,729)
Net Income (10,232) (2,339) (7,038) (13,981)
Total Assets 4,716 6,546 13,517 19,705
Total Debt 0 0 155 1,007
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Arcadia Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Arcadia Biosciences‘s full profile, request access.

Request a free trial

Arcadia Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation i
Cultivation
Dallas, TX
8 As of 2025

Chicago, IL
 

Wageningen, Netherlands
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Arcadia Biosciences Competitors (3)

One of Arcadia Biosciences’s 3 competitors is Archer Daniels Midland, a Corporation company based in Chicago, IL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Archer Daniels Midland Corporation Chicago, IL
Keygene Corporate Backed or Acquired Wageningen, Netherlands
Amyris (Biotechnology) Private Equity-Backed Emeryville, CA
You’re viewing 3 of 3 competitors. Get the full list »

Arcadia Biosciences Patents

Arcadia Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022081864-A1 Methods and compositions for increasing genetic diversity in cannabis plants Inactive 14-Oct-2020
AU-2021336542-A1 Methods of increasing fiber in a wheat grain Inactive 07-Sep-2020
CA-3191219-A1 Methods of increasing fiber in a wheat grain Pending 07-Sep-2020
EP-4211250-A1 Methods of increasing fiber in a wheat grain Inactive 07-Sep-2020
US-20230413751-A1 Methods of increasing fiber in a wheat grain Inactive 07-Sep-2020 A01H1/103
To view Arcadia Biosciences’s complete patent history, request access »

Arcadia Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Arcadia Biosciences Investments & Acquisitions (11)

Arcadia Biosciences’s most recent deal was a Seed Round with Fauna Bio for . The deal was made on 21-Sep-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Fauna Bio 21-Sep-2021 Seed Round Drug Discovery
Lief Holdings 17-May-2021 Merger/Acquisition Personal Products
Saavy Naturals 17-May-2021 Merger/Acquisition Personal Products
Zola (Beverages) 17-May-2021 Merger/Acquisition Beverages
Vivagran 19-Apr-2021 Merger/Acquisition Cultivation
You’re viewing 5 of 11 investments and acquisitions. Get the full list »

Arcadia Biosciences ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

39.09 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Food Products

Industry

of 508

Rank

Percentile

Soft Drinks

Subindustry

of 47

Rank

Percentile

To view Arcadia Biosciences’s complete esg history, request access »

Arcadia Biosciences Exits (3)

Arcadia Biosciences’s most recent exit was on 17-May-2021 from Saavy Naturals. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Saavy Naturals 17-May-2021 Completed
Verdeca 28-Feb-2012 Completed
  • 2 buyers
Bioceres Crop Solutions Corporate Completed
  • 3 buyers
To view Arcadia Biosciences’s complete exits history, request access »

Arcadia Biosciences Affiliates

Subsidiaries (2)

Name Industry Location Year Founded
Vivagran Barcelona, Spain 2006
Zola (Beverages) Dallas, TX 2001

Arcadia Biosciences FAQs

  • When was Arcadia Biosciences founded?

    Arcadia Biosciences was founded in 2002.

  • Where is Arcadia Biosciences headquartered?

    Arcadia Biosciences is headquartered in Dallas, TX.

  • What is the size of Arcadia Biosciences?

    Arcadia Biosciences has 8 total employees.

  • What industry is Arcadia Biosciences in?

    Arcadia Biosciences’s primary industry is Cultivation.

  • Is Arcadia Biosciences a private or public company?

    Arcadia Biosciences is a Public company.

  • What is Arcadia Biosciences’s stock symbol?

    The ticker symbol for Arcadia Biosciences is RKDA.

  • What is the current stock price of Arcadia Biosciences?

    As of 18-Nov-2026 the stock price of Arcadia Biosciences is $0.19.

  • What is the current market cap of Arcadia Biosciences?

    The current market capitalization of Arcadia Biosciences is $1.14M.

  • What is Arcadia Biosciences’s current revenue?

    The trailing twelve month revenue for Arcadia Biosciences is $5.06M.

  • Who are Arcadia Biosciences’s competitors?

    Archer Daniels Midland, Keygene, and Amyris (Biotechnology) are competitors of Arcadia Biosciences.

  • What is Arcadia Biosciences’s annual earnings per share (EPS)?

    Arcadia Biosciences’s EPS for 12 months was -$3.37.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process